Flow direct: next generation urine LFA for TB diagnosis in point-of-care settings
Active Project Grant Awarded Last action
- Award ID
- R44AI184104
- Recipient
-
Salus Discovery LLC UEI YJ6CYLKZ4JL9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,216,186
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 74% complete
- Originally
- Place of performance
- Madison, WI 53703, USA
Award details come from USAspending.gov.
Description
- Abstract
- Mycobacterium tuberculosis (TB) is a global threat to human health and accounts for 20% of adult deaths in low- income countries (~1.6 million deaths/year), yet only ~23% of new TB patients receive a who recommended nucleic acid test, while 37% receive tests with significantly lower sensitivity (e.g., smear microscopy), and ~40% cases do not have access to testing. The critical GAP in TB diagnostics, and the weakest link in global TB care, is access to high-quality TB testing. In order to address this, the who has developed target product profiles for the highest-priority TB diagnostic technologies and key among them is an affordable (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $999,991 | |
| Amendment | $916,195 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R44AI184104?
R44AI184104 was awarded to Salus Discovery LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 10, 2024.
How much is award R44AI184104 worth?
$2,216,186 has been obligated on R44AI184104.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award